School of Medicine
Showing 1-20 of 57 Results
-
Lei (Stanley) Qi
Associate Professor of Bioengineering
On Leave from 01/01/2023 To 06/30/2023BioDr. Lei (Stanley) Qi is Associate Professor of Bioengineering, Sarafan ChEM-H, and a Chan Zuckerberg Biohub Investigator. Dr. Qi is one major contributor to the development of CRISPR technology for genome engineering. His lab developed the first nuclease-deactivated Cas9 (dCas9) for gene targeting and regulation in cells. His lab invents a series of CRISPR tools, including CRISPRi and CRISPRa for targeted gene regulation, epigenome editing, LiveFISH for live cell imaging, CRISPR-GO for 3D genome manipulation, CasMINI as a miniature CRISPR for gene therapy, hyperCas12a for multigene engineering, and CRISPR antivirals for treating SARS-CoV-2. His lab is broadly interested in mammalian synthetic biology, epigenome engineering, immune cell engineering, directed evolution, and novel gene therapy. They also actively investigates the functional role of human noncoding genome. Dr. Qi obtained B.S. in Physics and Math from Tsinghua University, Ph.D. in Bioengineering from the University of California, Berkeley, and was a UCSF Systems Biology Fellow. He joined the faculty at Stanford University in 2014.
-
Zhen Qi
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsMy research focuses on understanding the mechanisms of breast cancer initiation and progression.
-
Xiang Qian
Stanford Medicine Endowed Director
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsClinical Interests
-Pain Medicine:
Facial pain
Migraine and headache
Trigeminal Neuralgia and Glossopharyngeal neuralgia
Cancer Pain
Spine Disease
Neuropathic pain
Interventional Surgery
CT guided Procedure
Opioid Management
-Facial Nerve neuralgia and neuropathy
Hemifacial Spasm
CT guided awake RFA of facial nerve
Research Interests:
-Medical device development
-AI based headache diagnosis and management
-CT guided intervention
-Intra-nasal endoscopy guided procedure
-Optogenetics
-Mechanisms of neuropathic pain
-Ion channel and diseases
-Neurotoxicity of anesthetics -
Yushen Qian, MD
Clinical Assistant Professor, Radiation Oncology - Radiation Therapy
BioDr. Qian is a board-certified radiation oncologist and a clinical assistant professor in the Stanford University School of Medicine, Department of Radiation Oncology.
In his clinical practice, he specializes in urologic, head and neck, and thoracic cancers, but treats a broad spectrum of cancers including lymphoma, gastrointestinal, and brain tumors. For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to deliver the most effective cancer treatment to help patients enjoy the best possible health and quality of life.
In addition to his clinical practice, Dr. Qian has conducted extensive research that is often focused on the impact of radiation therapy on patient outcomes and health care system costs.
He has presented the findings at annual meetings of the American Radium Society, American Society for Radiation Oncology, American Society of Clinical Oncology Cancer Survivorship Symposium, Palliative Care in Oncology Symposium, and elsewhere.
Dr. Qian has published articles in journals such as Clinical Cancer Research, the Journal of Clinical Oncology, Practical Radiation Oncology, the International Journal of Radiation Oncology • Biology • Physics (IJROBP), and more.
Dr. Qian co-authored the chapter on radiation therapy for liver tumors in the book Radiation Therapy for Hepatocellular Carcinoma: Clinical Data. He also co-authored the chapter on liver care for the book Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.
He has earned numerous honors, including the Malcolm A. Bagshaw Award for leadership and outstanding scientific achievement.